TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cca.2017.05.019PMID 28526535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Advances in the pathogenesis of vascular endothelial cells injury in Kawasaki disease].

  2016cited by this paper
• Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study

  2016cited by this paper
• Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?

  2016cited by this paper
• TNF-α induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model.

  2016cited by this paper
• Endothelial microparticles induce vascular endothelial cell injury in children with Kawasaki disease.

  2016cited by this paper
• Incomplete Kawasaki disease induced by measles in a 6‐month‐old male infant

  2016cited by this paper
• Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease

  2016cited by this paper
• Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells

  2015cited by this paper
• Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012

  2015cited by this paper
• Hypertension Triggers the Rupture of Coronary Artery Aneurysm in an 8‐Year‐Old Boy With Kawasaki Disease

  2014cited by this paper
• Association between Adipokines and Coronary Artery Lesions in Children with Kawasaki Disease

  2014cited by this paper
• Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease.

  2013cited by this paper
• Plasma endothelial microparticles, TNF-α and IL-6 in Kawasaki disease

  2013cited by this paper
• Immune‐monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin

  2013cited by this paper
• Anti‐inflammatory effects of high‐dose IgG on TNF‐α‐activated human coronary artery endothelial cells

  2012cited by this paper
• Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis

  2012cited by this paper
• A genome-wide association study identifies three new risk loci for Kawasaki disease

  2012cited by this paper
• Epidemiology of Kawasaki Disease in Asia, Europe, and the United States

  2012cited by this paper
• [Effects of intravenous immunoglobulin and aspirin treatment on the functions of circulating endothelial progenitor cells in children with Kawasaki disease].

  2011cited by this paper
• ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

  2011cited by this paper
• Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

  2011cited by this paper
• Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease

  2010cited by this paper
• The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease

  2010cited by this paper
• Tumor necrosis factor-α signaling in macrophages.

  2010cited by this paper
• Infliximab Treatment for Refractory Kawasaki Disease in Korean Children

  2010cited by this paper
• Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease.

  2010cited by this paper
• Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age

  2009cited by this paper
• Epidemiologic Features of Kawasaki Disease in Taiwan, 2003–2006

  2009cited by this paper
• A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease

  2009cited by this paper
• Inhibition of matrix metalloproteinase‐9 activity improves coronary outcome in an animal model of Kawasaki disease

  2009cited by this paper
• Kawasaki disease: summary of the American Heart Association guidelines.

  2006cited by this paper
• TNF-α Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease1

  2006cited by this paper
• Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure

  2006cited by this paper
• ASSOCIATION BETWEEN LEVELS OF TNF-α AND TNF-α PROMOTER -308 A/A POLYMORPHISM IN CHILDREN WITH KAWASAKI DISEASE

  2003cited by this paper
• [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].

  2003cited by this paper
• Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea.

  2003cited by this paper
• Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease.

  2003cited by this paper
• Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease

  2001cited by this paper
• Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

  1999cited by this paper
• Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group.

  1998cited by this paper
• Inhibition of IL‐12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD)

  1998cited by this paper

• A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China

  2025cites this paper
• Single-cell transcriptomic analysis reveals a systemic immune dysregulation in intravenous immunoglobulin non-responsive Kawasaki disease

  2025cites this paper
• Cholestasis as a complication in Kawasaki disease: an atypical clinical presentation

  2025cites this paper
• Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response

  2025cites this paper
• Activated partial thromboplastin time levels and coronary artery lesions in Kawasaki disease: A retrospective cohort study.

  2025cites this paper
• Chrysin improves endothelial inflammation via the NFAT pathway in Kawasaki disease

  2025cites this paper
• Clinical characteristics of cervical lymphadenopathy in Kawasaki disease and the generation of related cervical complications: a retrospective cohort study

  2025cites this paper
• A novel format of TNF-α binding affibody molecule ameliorate coronary artery endothelial injury in a mouse model of Kawasaki disease.

  2024cites this paper
• Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

  2024cites this paper
• Case Series on the Efficacy and Safety of Tocilizumab in IVIG-Resistant Kawasaki Disease: A Retrospective Analysis of Five Patients

  2024cites this paper
• Refractory Kawasaki Disease With a Giant Aneurysm Successfully Treated With Infliximab and Enoxaparin: A Case Report.

  2024cites this paper
• The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement

  2024cites this paper
• Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST

  2023cites this paper
• Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.

  2023cites this paper
• Clinical characteristics and correlation analysis of IVIG resistance in children with kawasaki disease complicated with hip synovitis: case-control study

  2023cites this paper
• Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study

  2023cites this paper
• Kawasaki Disease: 10-year Single-center Experience: Analysis of Clinical and Laboratory Findings with Treatment Approaches

  2023cites this paper
• Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review

  2022cites this paper
• Extracardiovascular injury complications in Kawasaki disease

  2022cites this paper
• Reduning Injection prevents carrageenan-induced inflammation in rats by serum and urine metabolomics analysis

  2022cites this paper
• Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease.

  2022cites this paper
• Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness

  2021cites this paper
• Higher Efficacy of Infliximab than Immunoglobulin on Kawasaki Disease, a Meta-analysis.

  2021cites this paper
• Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease

  2021cites this paper
• Diagnostic Value of Immune-Related Genes in Kawasaki Disease

  2021cites this paper
• The clinical implications of serum ferritin in Kawasaki disease: a helpful biomarker for evaluating therapeutic responsiveness, coronary artery involvement and the tendency of macrophage activation syndrome

  2021influential citation
• Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease

  2020cites this paper
• Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study

  2020cites this paper
• Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study

  2020cites this paper
• Assessment of coronary artery abnormalities and variability of Z‐score calculation in the acute episode of Kawasaki disease—A retrospective study from China

  2020cites this paper
• Decreased hemoglobin after initial treatment is associated with treatment resistance in Kawasaki disease in Kobayashi risk stratification

  2020cites this paper
• Kawasaki syndrome: role of superantigens revisited

  2020cites this paper
• The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid

  2020cites this paper
• Tumour necrosis factor‐α and myoglobin associated with the recovery time of coronary artery lesions in Kawasaki disease patients

  2020cites this paper
• Usefulness of Kawasaki disease risk scoring systems to the Turkish population

  2020cites this paper
• Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies

  2020cites this paper
• Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease

  2020influential citation
• Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children

  2020cites this paper
• Do Cytokines Correlate with Refractory Kawasaki Disease in Children?

  2020cites this paper
• Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

  2019cites this paper
• Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm

  2019cites this paper
• A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old

  2019cites this paper
• Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review

  2019cites this paper
• Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities

  2019cites this paper
• Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway

  2019cites this paper
• The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease

  2019cites this paper
• Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease

  2019cites this paper
• Anti-Inflammatory Effects of Gingerol on Lipopolysaccharide-Stimulated RAW 264.7 Cells by Inhibiting NF-κB Signaling Pathway

  2018cites this paper
• Predictors of First Dose of Immunoglobulin Resistance in Children with Kawasaki Disease

  2018cites this paper
• Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy

  2018cites this paper
• Medical laboratory in autoimmunity 2017

  2017cites this paper
• World Journal of Clinical Pediatrics

  year unknowninfluential citation